Covered recipient · General Payments record
MIGUEL INOLINO ARGUELLES
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022
$167.73
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $167.73 | 9 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $62.32 | 3 |
| Lilly USA, LLC | $34.21 | 2 |
| Alkermes, Inc. | $22.41 | 1 |
| Acerta Pharma LLC | $19.02 | 1 |
| Collegium Pharmaceutical, Inc. | $15.61 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.16 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2022 | $167.73 | 9 |
Payment records · PY2022 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $22.41 | 09/20/2022 | Food and Beverage | Undisputed | 01/23/2026 | 925806079 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.02 | 11/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 915035579 | CMS |
| Collegium Pharmaceutical, Inc. | $15.61 | 11/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 914549841 | CMS |
| Lilly USA, LLC | $17.70 | 08/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918609367 | CMS |
| Lilly USA, LLC | $16.51 | 11/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918609369 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.16 | 11/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 959385573 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.54 | 10/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954780311 | CMS |
| Teva Pharmaceuticals USA, Inc. | $12.10 | 10/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954780215 | CMS |
| Teva Pharmaceuticals USA, Inc. | $28.68 | 11/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954780317 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022
- Source files
- Dataset page · Bulk file · PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.